PTGX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Protagonist Therapeutics Inc (PTGX) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The company's strong pipeline, positive analyst sentiment, and improving financials, combined with favorable technical indicators, make it a compelling investment opportunity.
The MACD histogram is positive and expanding, indicating bullish momentum. RSI is neutral at 52.824, suggesting no overbought or oversold conditions. The stock is trading near its pivot level of 82.805, with support at 80.808 and resistance at 84.801. Moving averages are converging, indicating potential for a breakout.
Positive Phase 3 VERIFY data for rusfertide and a projected $3B peak sales in 2032 add to the bullish outlook.
No significant hedge fund or insider trading activity. Lack of recent news or congress trading data. The stock has a 40% chance of minor short-term declines based on historical candlestick patterns.
In Q3 2025, revenue increased by 0.79% YoY to $4.71M. Net income improved by 18.46% YoY but remains negative at -$39.34M. EPS improved by 14.81% YoY to -0.62. Gross margin remains strong at 100%.
Analysts are highly bullish, with recent price target increases from H.C. Wainwright ($117), Truist ($110), Barclays ($108), and Citi ($115). Analysts highlight the company's proven track record, regulatory milestones, and pipeline progress as key drivers for growth.
